Biopharma

STAT+: An interview with Christi Grimm, and ‘existentia...

This week in health care news: An interview with the fired HHS watchdog, inside ...

STAT+: Canada advances an antitrust probe into Express ...

Canadian officials have obtained a court order that requires Express Scripts to ...

Safety worries spur Pfizer to drop another obesity pill

Signs of potential liver damage in a study participant led the company to abando...

RFK Jr. blasts FDA as industry's 'sock puppet,' warns a...

In a Friday speech to FDA employees, the HHS secretary laid bare his belief that...

Third Harmonic outlines plans for dissolution

The Atlas-backed company plans to liquidate its assets, including an experimenta...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Capvaxive, pneumococca...

J&J MedTech reports first clinical cases with Ottava su...

J&J received a thumbs-up from the FDA last fall to launch human trials of the sy...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Lyvdelzi (previously S...

Pharma bosses face down investor angst on tariffs, HHS ...

As first quarter earnings begin, executives are confronting market turmoil, regu...

Dynastat

Dynastat

Sandoz takes Amgen to court again, challenging its pate...

Sandoz has filed an antitrust lawsuit in federal court in Virginia claiming that...

Agenda of the CAT meeting 14-16 April 2025

Agenda of the CAT meeting 14-16 April 2025

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Stelara, ustekinumab, ...

Evaluation of medicinal products indicated for treatmen...

Evaluation of medicinal products indicated for treatment of bacterial infections...

Verve’s second swing at gene editing for heart disease ...

Wall Street analysts said the results for Verve’s therapy appeared competitive o...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Rezolsta, darunavir,co...

Ironwood rethinks options after FDA demands another pha...

Ironwood Pharmaceuticals has been left considering its options after the FDA dem...

American College of Physicians, April 3-5

The annual meeting of the American College of Physicians (Internal Medicine Meet...

Healthy Nutrition, Activity May Reduce Mortality Risk f...

MONDAY, April 14, 2025 -- Adherence to American Cancer Society (ACS) nutrition ...

Medial Temporal Lobectomy Aids Seizure Outcomes in Epil...

MONDAY, April 14, 2025 -- Medial temporal lobectomy is effective in improving s...

Brain Functional Networks Affected by Neoadjuvant Chemo...

MONDAY, April 14, 2025 -- For patients with breast cancer, the brain functional...

Lower Oral Health Scores Linked to Higher Pain Scores i...

MONDAY, April 14, 2025 -- Low oral health scores are associated with higher pai...

Link Between Global β-Amyloid, Tau Deposition Varies by...

MONDAY, April 14, 2025 -- Women and individuals with a paternal history of Alzh...

Prostate Cancer Screening Program Beneficial in Top Dec...

MONDAY, April 14, 2025 -- A prostate cancer screening program involving partici...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.